The U.S. Food & Drug Administration (FDA) has decided to fast track SELLAS™ Life Sciences’ new drug Galinpepimut-S to treat pleural mesothelioma […]
|
||||
The U.S. Food & Drug Administration (FDA) has decided to fast track SELLAS™ Life Sciences’ new drug Galinpepimut-S to treat pleural mesothelioma […] Biopharmaceutical company Epizyme, Inc. is starting a new phase two clinical trial using tazemetostat as a treatment for mesothelioma cancer. […] Some scientists believe combination therapies such as those used for AIDS patients could eventually cure cancer […] |